Immune cell therapy for early-stage brain tumors
Treatments studied
Part of Brain & nervous system, Cancer clinical trials.
This trial tests whether giving patients immune cells called cytokine-induced killer cells can help treat early-stage brain tumors (grade 1 or 2 gliomas). It may help keep the tumor from growing or coming back after standard treatments like radiation and chemotherapy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a grade 1 or 2 brain tumor (glioma).
- You have already had radiation therapy for a higher-grade tumor (grade 3 or 4) with a total dose of at least 40 Gy.
- You have completed at least one full cycle of the chemotherapy drug temozolomide without serious side effects or the tumor getting worse.
- You are at least 18 years old and are in generally good health (able to care for yourself, Karnofsky score 60 or more).
- You are not pregnant or breastfeeding, and you agree to use contraception if applicable.
- You do not have diabetes, HIV, or other serious uncontrolled medical conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment using your own immune cells, called cytokine-induced killer cells, to fight advanced brain cancer (glioblastoma). It may help people whose cancer has returned after standard chemotherapy.
This study is testing a new type of immune cell therapy (cytokine-induced killer cells) for people with glioblastoma, a type of brain cancer. The treatment may boost your immune system to fight the cancer.
This trial tests a new treatment using donated natural killer (NK) cells injected into the body to fight high-grade brain tumors. It might help people with certain types of aggressive gliomas that are newly diagnosed.
This early-stage study tests a treatment made from your tumor’s immune cells (TILs) to help shrink brain glioma. You may be considered if your glioma is back or has spread and standard options are no longer working (or don’t exist).
This Phase 1 trial tests a gene-edited immune cell treatment given into the brain to treat recurrent (returning) grade 4 glioblastoma or related tumors. It aims to find a safe dose and see whether the treatment can slow tumor growth.
This early-phase study tests an immune cell treatment (natural killer cells) plus temozolomide to treat melanoma that has spread to the brain. It’s for people whose brain spots are getting worse and who are not good candidates for certain types of brain radiation.
Hear when a new Cytokine-Induced Killer Cells trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.